 Connection
Jason Burdick to Myocardial Ischemia
This is a "connection" page, showing publications Jason Burdick has written about Myocardial Ischemia.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.271 |
|
|
|
-
Gaffey AC, Chen MH, Venkataraman CM, Trubelja A, Rodell CB, Dinh PV, Hung G, MacArthur JW, Soopan RV, Burdick JA, Atluri P. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium. J Thorac Cardiovasc Surg. 2015 Nov; 150(5):1268-76.
Score: 0.101
-
Cohen JE, Purcell BP, MacArthur JW, Mu A, Shudo Y, Patel JB, Brusalis CM, Trubelja A, Fairman AS, Edwards BB, Davis MS, Hung G, Hiesinger W, Atluri P, Margulies KB, Burdick JA, Woo YJ. A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy. Circ Heart Fail. 2014 Jul; 7(4):619-26.
Score: 0.093
-
Elser JA, Purcell BP, Allana IA, Burdick JA, Margulies KB. Ischemia induces P-selectin-mediated selective progenitor cell engraftment in the isolated-perfused heart. J Mol Cell Cardiol. 2012 Jan; 52(1):105-12.
Score: 0.078
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|